The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ashton Paul since 2014.
The trader's CIK number is 1410243.
At the time of the last reporting, Ashton Paul was the President & CEO of Eyepoint Pharmaceuticals, Inc.. (stock ticker symbol EYPT).
Also see all insider trading activities at Eyepoint Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | PSDV | 0 | $0 | 0 | $0 | 10,000 | $11,299 |
| 2015 | PSDV | 0 | $0 | 120,000 | $646,800 | 120,000 | $135,600 |
| 2014 | PSDV | 0 | $0 | 70,000 | $297,679 | 70,000 | $79,090 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-03-18 | PSDV | Option Ex | 10,000 | 1.13 | 11,299 |
| 2015-12-22 | PSDV | Sale | 120,000 | 5.39 | 646,800 |
| 2015-12-22 | PSDV | Option Ex | 120,000 | 1.13 | 135,600 |
| 2014-10-01 | PSDV | Sale | 10,000 | 4.27 | 42,699 |
| 2014-10-01 | PSDV | Option Ex | 10,000 | 1.13 | 11,299 |
| 2014-09-02 | PSDV | Option Ex | 10,000 | 1.13 | 11,299 |
| 2014-09-02 | PSDV | Sale | 10,000 | 4.78 | 47,800 |
| 2014-08-01 | PSDV | Option Ex | 10,000 | 1.13 | 11,299 |
| 2014-08-01 | PSDV | Sale | 10,000 | 4.37 | 43,700 |
| 2014-07-01 | PSDV | Option Ex | 10,000 | 1.13 | 11,299 |
| 2014-07-01 | PSDV | Sale | 10,000 | 4.32 | 43,200 |
| 2014-06-18 | PSDV | Option Ex | 3,931 | 1.13 | 4,442 |
| 2014-06-19 | PSDV | Option Ex | 3,069 | 1.13 | 3,467 |
| 2014-06-18 | PSDV | Sale | 3,931 | 4.00 | 15,724 |
| 2014-06-19 | PSDV | Sale | 3,069 | 4.00 | 12,276 |
| 2014-06-16 | PSDV | Option Ex | 3,200 | 1.13 | 3,615 |
| 2014-06-17 | PSDV | Option Ex | 4,500 | 1.13 | 5,084 |
| 2014-06-16 | PSDV | Sale | 3,200 | 4.01 | 12,832 |
| 2014-06-17 | PSDV | Sale | 4,500 | 4.00 | 18,000 |
| 2014-06-12 | PSDV | Option Ex | 9,600 | 1.13 | 10,847 |
| 2014-06-13 | PSDV | Sale | 2,200 | 4.01 | 8,822 |
| 2014-06-12 | PSDV | Sale | 9,600 | 4.02 | 38,591 |
| 2014-06-13 | PSDV | Option Ex | 2,200 | 1.13 | 2,485 |
| 2014-05-05 | PSDV | Option Ex | 3,500 | 1.13 | 3,954 |
| 2014-05-05 | PSDV | Sale | 3,500 | 4.01 | 14,035 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ashton Paul (President & CEO of Eyepoint Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.